COH: Provisional findings from the UK CMA
COCHLEAR LIMITED π π π
- The UK Competition and Markets Authority (CMA) has provisionally found that Cochlear's proposed acquisition of Oticon Medical may substantially lessen competition in the bone conduction solutions market in the UK.
- Cochlear disagrees with the CMA's conclusions and maintains its commitment to innovation and providing better hearing solutions to more people.
- The acquisition is conditional on approval from the CMA, the Australian Competition and Consumer Commission, and the European Commission, and is no longer expected to close before 30 June 2023.

2023-04-20 16:59:00